7Baggers

Sanofi Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Long-Term Debt  
 Short-Term Debt  
 Inventory  
20021231 20031231 20041231 20051231 20071231 20081231 20091231 20101231 20111231 20161231 20171231 20201231 20211231 20221231 20231231 03.356.7110.0613.4116.7720.1223.48Billion

Sanofi Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2022-12-31 2021-12-31 2020-12-31 2017-12-31 2016-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2005-12-31 2004-12-31 2003-12-31 2002-12-31 
                 
  property, plant and equipment10,160 9,869 10,028 9,365 9,579 10,019 10,750 8,155 7,830 6,961 6,538 6,184 5,886,000,000   
  right-of-use assets1,654 1,815 1,948 1,198            
  goodwill49,404 49,892 48,056 44,364 40,264 40,287 38,079 31,932 29,733 28,163 27,199 30,234 23,475,000,000  134,000,000 
  other intangible assets24,319 21,640 21,407 18,421 13,080 10,879 23,639 12,479       1,161,000,000 
  investments accounted for using the equity method424 677 250 201 2,863           
  other non-current assets3,218 3,095 3,127 2,734 3,364 2,820          
  non-current income tax assets188 242 175 248            
  deferred tax assets6,427 5,381 4,598 4,212 4,290 4,669 3,633 3,051 2,912 2,920 2,912 3,095    
  non-current assets95,794 92,611 89,589 80,743 73,440 71,564 79,307 58,185 56,175 56,584 59,361 73,537    
  inventories9,666 8,960 8,715 8,352 6,816 6,892 6,051 5,020 4,444 3,590 3,729 3,430 3,058,000,000  823,000,000 
  accounts receivable8,433 8,424 7,568 7,491 7,216 7,311 8,042 6,507 6,015 5,303 4,904 5,021 4,501,000,000  1,311,000,000 
  other current assets3,455 3,532 3,571 2,737 2,005 2,211 2,401 2,000 2,104 1,881 2,126 2,434 2,476,000,000  854,000,000 
  current income tax assets391 374 612 1,208            
  cash and cash equivalents8,710 12,736 10,098 13,915 10,315 10,273 4,124 6,465 4,692 4,226 1,711 1,249    
  current assets30,655 34,026 30,564 33,703 26,352 26,687 20,791 20,043 17,532 15,403 12,553 13,121    
  assets held for sale or exchange15 85 89 83 34 6,421 67 7,036 6,342       
  total assets126,464 126,722 120,242 114,529 99,826 104,672 100,165 85,264 80,049 71,987 71,914 86,658 76,755,000,000 9,749,000,000 9,459,000,000 
  f-2               
  equity attributable to equity holders of sanofi    58,089           
  equity attributable to non-controlling interests    169           
  total equity    58,258    48,446 45,071 44,719     
  long-term debt    14,326    5,961 4,173 3,734  8,638,000,000  65,000,000 
  non-current liabilities related to business combinations and to non-controlling interests    1,026           
  non-current provisions and other non-current liabilities    9,154           
  deferred tax liabilities    1,605    4,933 5,668 6,935     
  non-current liabilities    26,111    19,205 17,571 17,526     
  accounts payable    4,633    2,654 2,791 2,749  2,765,000,000  596,000,000 
  current liabilities related to business combinations and to non-controlling interests    343           
  current provisions and other current liabilities    9,206           
  short-term debt and current portion of long-term debt    1,275    2,866 1,833 2,207     
  current liabilities    15,457    10,965 9,345 9,669     
  liabilities related to assets held for sale or exchange        1,433       
  total equity and liabilities    99,826           
  investments in associates and joint ventures     2,890 807 924        
  consolidated balance sheets – liabilities and equity               
  assets               
  non-current financial assets      2,399 1,644        
  current financial assets      173 51        
  in accordance with ifrs 3 (business combinations), sanofi-aventis adjusted the values of certain identifiable assets and liabilities of merial during the purchase price allocation period (see note d.1.).               
  intangible assets        13,747 15,260 19,182 30,229    
  investments in associates        955 2,459 2,493 2,477    
  financial assets — non-current        998 821      
  financial assets — current        277 403      
  liabilities & equity               
  equity attributable to equity holders of the company        48,188 44,866 44,542     
  minority interests        258 205 177  359,000,000  17,000,000 
  provisions and other non-current liabilities        8,311 7,730 6,857     
  other current liabilities        5,445 4,721 4,713  4,852,000,000  1,599,000,000 
  total liabilities & equity        80,049 71,987 71,914     
  assets held for sale           676    
  liabilities related to assets held for sale               
  financial assets – non-current          1,037 1,318    
  financial assets – current          83 311    
  as allowed under ifrs 3, sanofi-aventis has revised certain preliminary estimates of the aventis purchase price allocation within the permitted 12-month period.               
  patents, licenses and other intangibles            29,600,000,000   
  long-term investments               
  equity investees            2,404,000,000   
  other investments and advances            11,000,000   
  other long-term investments            929,000,000  73,000,000 
  total fixed assets            62,305,000,000 2,712,000,000 2,899,000,000 
  deferred income taxes            1,925,000,000 472,000,000 484,000,000 
  short-term investments and deposits            958,000,000  2,944,000,000 
  cash            1,532,000,000  144,000,000 
  in millions of euros               
  liabilities and shareholders’ equity               
  shareholders’ equity               
  share capital            2,823,000,000  1,465,000,000 
  additional paid in capital and reserves            39,377,000,000  2,971,000,000 
  net income for the period              1,759,000,000 
  cumulative translation adjustment               
  total shareholders’ equity            35,574,000,000  6,035,000,000 
  other equity instruments            16,000,000   
  provisions and other long-term liabilities            5,768,000,000  786,000,000 
  short-term debt            7,388,000,000  351,000,000 
  total liabilities and shareholders’ equity            76,755,000,000  9,459,000,000 
  inventories, accounts receivable & other current assets             3,187,000,000  
  short-term investments and deposits, cash             3,378,000,000  
  gross              1,989,000,000 
  accumulated depreciation               
  net              1,395,000,000 
  investments in/advances to equity investees              109,000,000 
  investments in/advances to non-consolidated companies              27,000,000 

We provide you with 20 years of balance sheets for Sanofi stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Sanofi. Explore the full financial landscape of Sanofi stock with our expertly curated balance sheets.

The information provided in this report about Sanofi stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.